Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Aranda JV, Qu J, Valencia GB, Beharry KD.

Semin Perinatol. 2019 Oct;43(6):360-366. doi: 10.1053/j.semperi.2019.05.009. Epub 2019 May 11. Review.

PMID:
31153620
2.

Combined antenatal and postnatal steroid effects on fetal and postnatal growth, and neurological outcomes in neonatal rats.

Abrantes MA, Valencia AM, Bany-Mohammed F, Aranda JV, Beharry KD.

Am J Transl Res. 2019 Mar 15;11(3):1697-1710. eCollection 2019.

3.

Development of a Retinopathy of Prematurity Activity Scale and Clinical Outcome Measures for Use in Clinical Trials.

Smith LEH, Hellström A, Stahl A, Fielder A, Chambers W, Moseley J, Toth C, Wallace D, Darlow BA, Aranda JV, Hallberg B, Davis JM; Retinopathy of Prematurity Workgroup of the International Neonatal Consortium.

JAMA Ophthalmol. 2019 Mar 1;137(3):305-311. doi: 10.1001/jamaophthalmol.2018.5984.

4.

Reactive Oxygen Species, Biomarkers of Microvascular Maturation and Alveolarization, and Antioxidants in Oxidative Lung Injury.

Valencia AM, Abrantes MA, Hasan J, Aranda JV, Beharry KD.

React Oxyg Species (Apex). 2018 Nov;6(18):373-388. doi: 10.20455/ros.2018.867.

5.

Comparative Effects of Coenzyme Q10 or n-3 Polyunsaturated Fatty Acid Supplementation on Retinal Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy.

Beharry KD, Cai CL, Siddiqui F, Chowdhury S, D'Agrosa C, Valencia GB, Aranda JV.

Antioxidants (Basel). 2018 Nov 9;7(11). pii: E160. doi: 10.3390/antiox7110160.

6.

Dose response effects of postnatal hydrocortisone on growth and growth factors in the neonatal rat.

Abrantes MA, Valencia AM, Bany-Mohammed F, Aranda JV, Beharry KD.

Steroids. 2018 Dec;140:1-10. doi: 10.1016/j.steroids.2018.08.003. Epub 2018 Aug 22.

PMID:
30142369
7.

SiRNA silencing of VEGF, IGFs, and their receptors in human retinal microvascular endothelial cells.

Nicolau Y, Bany-Mohammed F, Cai CL, Aranda JV, Beharry KD.

Am J Transl Res. 2018 Jul 15;10(7):1990-2003. eCollection 2018.

8.

Chronic Intermittent Hypoxia Causes Lipid Peroxidation and Altered Phase 1 Drug Metabolizing Enzymes in the Neonatal Rat Liver.

Cai C, Aranda JV, Valencia GB, Xu J, Beharry KD.

React Oxyg Species (Apex). 2017 May;3(9):218-236. Epub 2017 May 1.

9.

Oxygen-Induced Retinopathy from Recurrent Intermittent Hypoxia Is Not Dependent on Resolution with Room Air or Oxygen, in Neonatal Rats.

Beharry KD, Cai CL, Skelton J, Siddiqui F, D'Agrosa C, Calo J, Valencia GB, Aranda JV.

Int J Mol Sci. 2018 May 1;19(5). pii: E1337. doi: 10.3390/ijms19051337.

10.

Impact of Chronic Neonatal Intermittent Hypoxia on Severity of Retinal Damage in a Rat Model of Oxygen-Induced Retinopathy.

Beharry KD, Cai CL, Ahmad T, Guzel S, Valencia GB, Aranda JV.

J Nat Sci. 2018;4(3). pii: e488.

11.

Intermittent hypoxia suppression of growth hormone and insulin-like growth factor-I in the neonatal rat liver.

Cai C, Ahmad T, Valencia GB, Aranda JV, Xu J, Beharry KD.

Growth Horm IGF Res. 2018 Aug;41:54-63. doi: 10.1016/j.ghir.2018.03.001. Epub 2018 Mar 8.

12.

Co-Enzyme Q10 and n-3 Polyunsaturated Fatty Acid Supplementation Reverse Intermittent Hypoxia-Induced Growth Restriction and Improved Antioxidant Profiles in Neonatal Rats.

Beharry KD, Cai CL, Henry MM, Chowdhury S, Valencia GB, Aranda JV.

Antioxidants (Basel). 2017 Dec 16;6(4). pii: E103. doi: 10.3390/antiox6040103.

13.

Evolution of Pharmacotherapeutics and Pharmacotoxidromes in Newborns and Children: Progress and Challenges.

Aranda JV.

Pediatr Clin North Am. 2017 Dec;64(6):xv-xvii. doi: 10.1016/j.pcl.2017.09.002. No abstract available.

PMID:
29173795
14.

Non-steroidal Anti-inflammatory Drugs in Newborns and Infants.

Aranda JV, Salomone F, Valencia GB, Beharry KD.

Pediatr Clin North Am. 2017 Dec;64(6):1327-1340. doi: 10.1016/j.pcl.2017.08.009. Review.

PMID:
29173788
15.

Intermittent hypoxia alters dose dependent caffeine effects on renal prostanoids and receptors in neonatal rats.

Beharry KD, Cai CL, Soontarapornchai K, Ahmad T, Valencia GB, Aranda JV.

Prostaglandins Other Lipid Mediat. 2018 Jan;134:57-65. doi: 10.1016/j.prostaglandins.2017.10.004. Epub 2017 Oct 26.

PMID:
29107023
16.

Enrollment of Neonates in More Than One Clinical Trial.

Davis JM, Baer GR, Portman R, Nelson R, Storari L, Aranda JV, Bax R, Zajicek A, Klein A, Turner M, Baygani S, Thomson M, Allegaert K; International Neonatal Consortium.

Clin Ther. 2017 Oct;39(10):1959-1969. doi: 10.1016/j.clinthera.2017.09.006. Epub 2017 Oct 4. Review.

17.

Human retinal endothelial cells and astrocytes cultured on 3-D scaffolds for ocular drug discovery and development.

Beharry KD, Cai CL, Valencia GB, Lazzaro D, Valencia AM, Salomone F, Aranda JV.

Prostaglandins Other Lipid Mediat. 2018 Jan;134:93-107. doi: 10.1016/j.prostaglandins.2017.09.005. Epub 2017 Sep 18.

18.

Ocular Adverse Effects of Intravitreal Bevacizumab Are Potentiated by Intermittent Hypoxia in a Rat Model of Oxygen-Induced Retinopathy.

Tan JJ, Cai CL, Shrier EM, McNally L, Lazzaro DR, Aranda JV, Beharry KD.

J Ophthalmol. 2017;2017:4353129. doi: 10.1155/2017/4353129. Epub 2017 Jul 9.

19.

Intravitreal bevacizumab alters type IV collagenases and exacerbates arrested alveologenesis in the neonatal rat lungs.

Valencia AM, Cai CL, Tan J, Duggan TJ, Valencia GB, Aranda JV, Beharry KD.

Exp Lung Res. 2017 Apr;43(3):120-133. doi: 10.1080/01902148.2017.1306897. Epub 2017 Apr 14.

PMID:
28409646
20.

Neonatal Intermittent Hypoxia, Reactive Oxygen Species, and Oxygen-Induced Retinopathy.

Beharry KD, Cai CL, Valencia GB, Valencia AM, Lazzaro DR, Bany-Mohammed F, Aranda JV.

React Oxyg Species (Apex). 2017 Jan;3(7):12-25. doi: 10.20455/ros.2017.805.

Supplemental Content

Loading ...
Support Center